No to Acta, yes to the right to health

The United Nations Special Rapporteur on the right to health, Anand Grover, praised the European Parliament’s rejection of the Anti-Counterfeiting Trade Agreement (ACTA) on July 4 as a step in the right direction to ensure continued access to affordable and essential drugs and medication essential for the fulfillment of the right to health

According to Grover, ACTA’s defeat in Europe was a welcome blow to the flawed agreement which had failed to address numerous concerns related to access to medicines. In July 2011, the UN Human Rights Council requested the Special Rapporteur to study existing challenges with regard to access to medicines, ways to overcome them and good practices. He will present the study to the Council in June 2013

10.07.2012

News • Threat to medical device availability

Cardiologists call for urgent MDR revision

While the Medical Device Regulation was designed to enhance safety and quality, its complexity and certification costs threaten the availability of vital devices. Cardiologists urge for revision.

News • Physicians' dilemma

Who is to blame for errors of medical AI?

Assistive AI systems are designed to ease the workload of physicians. However, implementation of the technology could actually worsen challenges related to error prevention and burnout, experts warn.

Article • A hard farewell from the lead apron

Radiation protection: Were we wrong all along?

For more than a year now, patients in Austria are no longer required to wear a lead apron during radiological imaging procedures such as X-ray and CT scans. However, the new recommendation, issued by…

Related articles